InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: ilovetech post# 279597

Friday, 06/12/2020 7:56:16 AM

Friday, June 12, 2020 7:56:16 AM

Post# of 426504
ilove..

I think you are missing the point..What the generics want and what they are going to get is a very wide gap..Throwing terms like "sex appeal" does not improve the quality or validity of a post..

The reason Amarin has had such a problem competing with Lovaza has nothing to do with incompetence...It has everything to do with the fact that until late Dec 2019 Amarin only had the MARINE label to rely on..Fact was Lovaza has the same label and it is cheaper..And the drug plans..after considering all other facts are going for cheaper..and in many states it is the law..So as we use to say.."you can stand on your head and spit wooden nickels", but those are the facts..

Now the generics Reddi and Hickma (H&R) are going to have to deal with those same facts and they are not going to do anything about them either..H&R do not have the R-I label indication.. Without that the generics are going to find they have next to nothing..The minute they try to go after R-I..Amarin will slap them with a patent infringement suit..

":>)JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News